SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (120)12/30/1998 11:27:00 AM
From: Michael Cash  Read Replies (1) | Respond to of 370
 
Would it be technically feasible to alter the so called "flesh-eating bacteria" to do it's devouring selectively against cancer cells? If it can be done with salmonella, why not with other microbes which have demonstrated far more aggressiveness?



To: scaram(o)uche who wrote (120)2/9/1999 8:41:00 AM
From: Jim Oravetz  Read Replies (3) | Respond to of 370
 
Richard: Any additional comments on the VION article in the January issue of Nature Biotechnology? The #119 message summary statement from VION was, to me, a pretty detailed coverage of the topic and the results.

Message 7657316

Message 7299148

Thanks, Jim


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News